Global Companion Diagnostics Market

Dec 2018| VMR290A| Verified Market Research

Report Highlights

The Global Companion Diagnostics Market was valued at USD 2.03 billion in 2016 and is projected to reach USD 10.30 billion by 2025, growing at a CAGR of 19.78% from 2017 to 2025.

A companion diagnostic is a medical device, often an in vitro device, which provides information that is essential for the safe and effective use of a corresponding drug or biological product.

Market Dynamics:
1. Market Drivers
1.1 Improvements in Regulatory Guidelines
1.2 Increase in the number of cancer patients all over the globe
1.3 Growing demands of targeted therapies
1.4 Increasing collaborations to promote companion diagnosis technology

2. Market Restraints
2.1 Reimbursement issues depending on regional economy

Market Segmentation:
1. Global Companion Diagnostics Market, by End User:
1.1 Pharma and Biotech Companies
1.2 Reference Laboratories
1.3 Others

2. Global Companion Diagnostics Market, by Indication:
2.1 Oncology
2.1.1 Breast Cancer
2.1.2 Lung Cancer
2.1.3 Colorectal Cancer
2.1.4 Melanoma
2.1.5 Gastric Cancer
2.1.6 Other Cancers Toiletries
2.2 Neurology
2.3 Infectious diseases
2.4 Other indications

3. Global Companion Diagnostics Market, by Products and Services:
3.1 Assay Kits and Reagents
3.2 Software & Services

4. Global Companion Diagnostics Market, by Region:
4.1 North America (U.S., Canada, Mexico)
4.2 Europe (Germany, UK, France, Rest of Europe)
4.3 Asia Pacific (China, India, Japan, Rest of Asia Pacific)
4.4 Latin America (Brazil, Argentina, Rest of Latin America)
4.5 Middle East & Africa

Competitive Landscape:
The major players in the market are as follows:
1. F. Hoffmann-La Roche AG
2. Agilent Technologies, Inc.
3. Qiagen N.V.
4. Thermo Fisher Scientific Inc.
5. Abbott Laboratories, Inc.
6. Biomérieux SA
7. Danaher Corporation
8. Illumina, Inc.
9. Myriad Genetics, Inc.
10. Arup Laboratories Inc.
11. Sysmex Corporation
12. Hologic Inc.
13. Novartis AG
14. Almac Group
15. Abnova Corporation

These major players have adopted various organic as well as inorganic growth strategies such as mergers & acquisitions, new product launches, expansions, agreements, joint ventures, partnerships, and others to strengthen their position in this market.

Research study on the Companion Diagnostics Marketwas performed in five phases which include Secondary research, Primary research, subject matter expert advice, quality check and final review.
The market data was analyzed and forecasted using market statistical and coherent models. Also market shares and key trends were taken into consideration while making the report. Apart from this, other data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Company Market Share Analysis, Standards of Measurement, Top to Bottom Analysis and Vendor Share Analysis.

To know more about the Research Methodology of Verified Market Intelligence and other aspects of the research study, kindly get in touch with our sales team.

Verified Market Research has been providing Research Reports, with up to date information, and in-depth analysis, for several years now, to individuals and companies alike that are looking for accurate Research Data. It has large database which includes the latest content from renowned authors and publications worldwide. It also provides customized Data and Reports according to the need of the client.

Why BCC Research?

Every purchase provides access to:

  • Thousands of recently published reports from select publishers
  • Member Discounts of up to 50% on over 20,000 additional reports from all publishers
  • Our analysts and research concierge for all inquiries

Need a custom data table, graph or complete report? Tell us more.

Contact Us
Share This Report